Skip to Content

MFS Blended Research Value Equity R4 BRUMX

Medalist Rating as of | See MFS Investment Hub
  • NAV / 1-Day Return 15.70  /  −0.06 %
  • Total Assets 282.0 Mil
  • Adj. Expense Ratio
    0.490%
  • Expense Ratio 0.490%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Large
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.32%
  • Turnover 51%

USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:16 PM GMT+0

Morningstar’s Analysis BRUMX

Will BRUMX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MFS Blended Research Value Equity R4’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BRUMX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

3.60 10.3 Mil
Financial Services

Johnson & Johnson

3.07 8.8 Mil
Healthcare

Wells Fargo & Co

2.32 6.6 Mil
Financial Services

Berkshire Hathaway Inc Class B

2.06 5.9 Mil
Financial Services

The Cigna Group

1.85 5.3 Mil
Healthcare

Salesforce Inc

1.85 5.3 Mil
Technology

Pfizer Inc

1.71 4.9 Mil
Healthcare

Phillips 66

1.71 4.9 Mil
Energy

Applied Materials Inc

1.65 4.7 Mil
Technology

Chubb Ltd

1.61 4.6 Mil
Financial Services